Home Healthcare Pharmaceuticals Urinary Tract Infection Therapeutics Market

Urinary Tract Infection Therapeutics Market Size, Share & Trends Analysis Report By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Other Drugs), By Indication (Complicated UTI, Uncomplicated UTI, Other Indications) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR3324DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Urinary Tract Infection Therapeutics Market, By Drug 2022-2034 (USD MILLION/ Units)
    1. Penicillin and Combinations
    2. Quinolones
    3. Cephalosporin
    4. Azoles and Amphotericin B
    5. Nitrofurans
    6. Other Drugs
  2. Urinary Tract Infection Therapeutics Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Complicated UTI
    2. Uncomplicated UTI
    3. Other Indications
  3. Regional Urinary Tract Infection Therapeutics Market
    1. North America
      1. North America Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Penicillin and Combinations
        2. Quinolones
        3. Cephalosporin
        4. Azoles and Amphotericin B
        5. Nitrofurans
        6. Other Drugs
      2. North America Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Complicated UTI
        2. Uncomplicated UTI
        3. Other Indications
      3. U.S. Urinary Tract Infection Therapeutics Market
        1. U.S. Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. U.S. Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      4. Canada Urinary Tract Infection Therapeutics Market
        1. Canada Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Canada Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
    2. Europe
      1. Europe Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Penicillin and Combinations
        2. Quinolones
        3. Cephalosporin
        4. Azoles and Amphotericin B
        5. Nitrofurans
        6. Other Drugs
      2. Europe Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Complicated UTI
        2. Uncomplicated UTI
        3. Other Indications
      3. U.K. Urinary Tract Infection Therapeutics Market
        1. U.K. Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. U.K. Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      4. Germany Urinary Tract Infection Therapeutics Market
        1. Germany Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Germany Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      5. France Urinary Tract Infection Therapeutics Market
        1. France Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. France Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      6. Spain Urinary Tract Infection Therapeutics Market
        1. Spain Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Spain Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      7. Italy Urinary Tract Infection Therapeutics Market
        1. Italy Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Italy Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      8. Russia Urinary Tract Infection Therapeutics Market
        1. Russia Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Russia Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      9. Nordic Urinary Tract Infection Therapeutics Market
        1. Nordic Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Nordic Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      10. Benelux Urinary Tract Infection Therapeutics Market
        1. Benelux Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Benelux Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      11. Rest of Europe Urinary Tract Infection Therapeutics Market
        1. Rest of Europe Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Rest of Europe Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
    3. APAC
      1. APAC Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Penicillin and Combinations
        2. Quinolones
        3. Cephalosporin
        4. Azoles and Amphotericin B
        5. Nitrofurans
        6. Other Drugs
      2. APAC Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Complicated UTI
        2. Uncomplicated UTI
        3. Other Indications
      3. China Urinary Tract Infection Therapeutics Market
        1. China Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. China Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      4. Korea Urinary Tract Infection Therapeutics Market
        1. Korea Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Korea Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      5. Japan Urinary Tract Infection Therapeutics Market
        1. Japan Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Japan Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      6. India Urinary Tract Infection Therapeutics Market
        1. India Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. India Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      7. Australia Urinary Tract Infection Therapeutics Market
        1. Australia Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Australia Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      8. Taiwan Urinary Tract Infection Therapeutics Market
        1. Taiwan Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Taiwan Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      9. South East Asia Urinary Tract Infection Therapeutics Market
        1. South East Asia Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. South East Asia Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      10. Rest of Asia-Pacific Urinary Tract Infection Therapeutics Market
        1. Rest of Asia-Pacific Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Rest of Asia-Pacific Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
    4. Middle East and Africa
      1. Middle East and Africa Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Penicillin and Combinations
        2. Quinolones
        3. Cephalosporin
        4. Azoles and Amphotericin B
        5. Nitrofurans
        6. Other Drugs
      2. Middle East and Africa Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Complicated UTI
        2. Uncomplicated UTI
        3. Other Indications
      3. UAE Urinary Tract Infection Therapeutics Market
        1. UAE Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. UAE Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      4. Turkey Urinary Tract Infection Therapeutics Market
        1. Turkey Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Turkey Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      5. Saudi Arabia Urinary Tract Infection Therapeutics Market
        1. Saudi Arabia Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Saudi Arabia Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      6. South Africa Urinary Tract Infection Therapeutics Market
        1. South Africa Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. South Africa Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      7. Egypt Urinary Tract Infection Therapeutics Market
        1. Egypt Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Egypt Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      8. Nigeria Urinary Tract Infection Therapeutics Market
        1. Nigeria Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Nigeria Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      9. Rest of MEA Urinary Tract Infection Therapeutics Market
        1. Rest of MEA Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Rest of MEA Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
    5. LATAM
      1. LATAM Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Penicillin and Combinations
        2. Quinolones
        3. Cephalosporin
        4. Azoles and Amphotericin B
        5. Nitrofurans
        6. Other Drugs
      2. LATAM Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Complicated UTI
        2. Uncomplicated UTI
        3. Other Indications
      3. Brazil Urinary Tract Infection Therapeutics Market
        1. Brazil Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Brazil Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      4. Mexico Urinary Tract Infection Therapeutics Market
        1. Mexico Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Mexico Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      5. Argentina Urinary Tract Infection Therapeutics Market
        1. Argentina Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Argentina Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      6. Chile Urinary Tract Infection Therapeutics Market
        1. Chile Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Chile Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      7. Colombia Urinary Tract Infection Therapeutics Market
        1. Colombia Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Colombia Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
      8. Rest of LATAM Urinary Tract Infection Therapeutics Market
        1. Rest of LATAM Urinary Tract Infection Therapeutics Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Penicillin and Combinations
          2. Quinolones
          3. Cephalosporin
          4. Azoles and Amphotericin B
          5. Nitrofurans
          6. Other Drugs
        2. Rest of LATAM Urinary Tract Infection Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Complicated UTI
          2. Uncomplicated UTI
          3. Other Indications
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.